These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8657361)

  • 1. Systemic NMDA antagonist CGP-37849 produces non-specific impairment in a working memory task: the effect does not resemble those of AP5 and of lesions of the hippocampus or fornix.
    Gutnikov SA; Rawlins JN
    Neuropsychologia; 1996 Apr; 34(4):311-4. PubMed ID: 8657361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5.
    Steele RJ; Morris RG
    Hippocampus; 1999; 9(2):118-36. PubMed ID: 10226773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor antagonists are less effective in blocking long-term potentiation at apical than basal dendrites in hippocampal CA1 of awake rats.
    Leung LS; Shen B
    Hippocampus; 1999; 9(6):617-30. PubMed ID: 10641754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic NMDA receptor antagonist CGP-40116 does not impair memory acquisition but protects against NMDA neurotoxicity in rhesus monkeys.
    Gutnikov SA; Gaffan D
    J Neurosci; 1996 Jun; 16(12):4041-5. PubMed ID: 8656297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the competitive NMDA receptor antagonist CGP 37849 on performance of reference and working memory tasks by rats.
    Deacon RM; Rawlins JN
    Eur J Pharmacol; 1995 Jul; 280(2):239-42. PubMed ID: 7589194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activity of two orally active competitive N-methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio.
    Chapman AG; Graham JL; Patel S; Meldrum BS
    Epilepsia; 1991; 32(4):578-87. PubMed ID: 1678345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal AP5 treatment impairs both spatial working and reference memory in radial maze performance in rats.
    Yamada K; Shimizu M; Kawabe K; Ichitani Y
    Eur J Pharmacol; 2015 Jul; 758():137-41. PubMed ID: 25863255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between NMDA and CB2 function in the dorsal hippocampus on memory consolidation impairment: an isobologram analysis.
    Nasehi M; Hajikhani M; Ebrahimi-Ghiri M; Zarrindast MR
    Psychopharmacology (Berl); 2017 Feb; 234(3):507-514. PubMed ID: 27858086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
    D'Hooge R; Raes A; Hiramatsu M; Mori A; Van Bogaert PP; De Deyn PP
    Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NMDA receptors is necessary for the induction of associative long-term potentiation in area CA1 of the rat hippocampal slice.
    Murphy KP; Reid GP; Trentham DR; Bliss TV
    J Physiol; 1997 Oct; 504 ( Pt 2)(Pt 2):379-85. PubMed ID: 9365912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of D-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid on ischemic brain damage induced by four-vessel occlusion in rats.
    Okada M; Fujimura Y; Ueda H; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 Feb; 47(2):115-9. PubMed ID: 9079228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
    Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
    Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
    Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
    J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of non-spatial working memory deficits in rats given intraventricular infusions of the NMDA antagonist AP5.
    Lyford GL; Gutnikov SA; Clark AM; Rawlins JN
    Neuropsychologia; 1993 Oct; 31(10):1079-98. PubMed ID: 7904731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective block of N-methyl-D-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP 40116.
    D'Hooge R; Raes A; Van Bogaert PP; Geelhand M; De Deyn PP
    Br J Pharmacol; 1997 Jan; 120(2):211-4. PubMed ID: 9117111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP.
    Zajaczkowski W; Frankiewicz T; Parsons CG; Danysz W
    Neuropharmacology; 1997 Jul; 36(7):961-71. PubMed ID: 9257940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intrahippocampal AP5 treatment on radial-arm maze performance in rats.
    Kawabe K; Ichitani Y; Iwasaki T
    Brain Res; 1998 Jan; 781(1-2):300-6. PubMed ID: 9507170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
    Zajaczkowski W; Czyrak A; Wedzony K
    Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.